These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer. Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM J Nucl Med; 2016 Jun; 57(6):936-42. PubMed ID: 26848176 [TBL] [Abstract][Full Text] [Related]
4. Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with Cai Z; Yook S; Lu Y; Bergstrom D; Winnik MA; Pignol JP; Reilly RM Pharm Res; 2017 Mar; 34(3):579-590. PubMed ID: 27987070 [TBL] [Abstract][Full Text] [Related]
5. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates. Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962 [TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelating Polymers Complexed to Aghevlian S; Cai Z; Lu Y; Hedley DW; Winnik MA; Reilly RM Mol Pharm; 2019 Feb; 16(2):768-778. PubMed ID: 30589553 [TBL] [Abstract][Full Text] [Related]
11. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534 [TBL] [Abstract][Full Text] [Related]
12. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315 [TBL] [Abstract][Full Text] [Related]
13. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer. Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy. Fonge H; Lee H; Reilly RM; Allen C Mol Pharm; 2010 Feb; 7(1):177-86. PubMed ID: 19924993 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells. Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028 [TBL] [Abstract][Full Text] [Related]
16. Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with Lai P; Cai Z; Pignol JP; Lechtman E; Mashouf S; Lu Y; Winnik MA; Jaffray DA; Reilly RM Phys Med Biol; 2017 Oct; 62(22):8581-8599. PubMed ID: 29077574 [TBL] [Abstract][Full Text] [Related]
17. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534 [TBL] [Abstract][Full Text] [Related]
18. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model. Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064 [TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, Aghevlian S; Cai Z; Hedley D; Winnik MA; Reilly RM EJNMMI Radiopharm Chem; 2020 Nov; 5(1):22. PubMed ID: 33169241 [TBL] [Abstract][Full Text] [Related]